The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rapiscan

400 microgram(s) Solution for injection

GE Healthcare ASEU/1/10/643/001

Main Information

Trade NameRapiscan
Active SubstancesRegadenoson
Strength400 microgram(s)
Dosage FormSolution for injection
Licence HolderGE Healthcare AS
Licence NumberEU/1/10/643/001

Group Information

ATC CodeC01EB Other cardiac preparations
C01EB21 regadenoson

Status

Authorised/WithdrawnAuthorised
Licence Issued06/09/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back